Page 2 - Liposomal Formulation Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liposomal formulation development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liposomal Formulation Development Today - Breaking & Trending Today

Welcome To IANS Live - NATION - Ramp-up stock of alternate drugs to treat black fungus: Punjab CM

With only Liposomal Amphotericin B injections in the stock and just 880 more Liposomal expected to be received shortly, the Chief Minister stressed the need to strengthen alternate drug stocks, as recommended by the expert group constituted by his government to deal with the crisis.Stre ....

Dakul Seth , News Service , India Private , Chief Minister Amarinder Singh , All Rights , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் , நீரிழிவு நோய் ,

Welcome To IANS Live - BUSINESS - Zydus & TLC sign agreement to market critical drug to treat Black Fungus

AmphoTLC is a critical drug to treat Mucormycosis or Black Fungus in India. Under the terms of the agreement, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to Zydus, and Zydus will commercialize AmphoTLC in India. The ....

New Delhi , Dakul Seth , News Service , India Private , Amphotericinb Liposome , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

A better and more stable phospholipid delivery system | Natural Products INSIDER

Plant-based Zeal Technology™ from Aurea Biolabs is a new phospholipid delivery system ....

Aurea Biolabs , Zeal Technology , வைராக்கியம் தொழில்நுட்பம் ,

Welcome To IANS Live - NATION - DGCI approves anti-fungal medicine for Covid-linked black fungus treatment

Photo Credit: IANS
IANSLive
New Delhi, March 14 (IANS) A Mumbai-based bio-pharmaceutical firm has received approval from India s drug regulatory authority to use an anti-fungal drug for the treatment of black fungus or Mucormycosis, which recently saw an uprise among the patients recovering from the Covid-19.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 14-March-2021 ....

New Delhi , News Service , India Private , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,